Overview
CRDF market data
Price History
CRDF price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CRDF. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
8-K filing — Cardiff Oncology, Inc. (CRDF)SEC EDGAR · Jul 16, 2026, 12:38 PM
Crude Oil Moves Lower; US Producer Prices Fall 0.3% In JuneBenzinga · Jul 15, 2026, 4:03 PM
Dow Gains Over 150 Points; Morgan Stanley Profit Tops ViewsBenzinga · Jul 15, 2026, 1:43 PM
Cardiff Oncology shares are trading lower after the company announced a $10 million offering of 8,571,429 shares of its common stock and accompanying warrants at $1.05 per share and accompanying warrant.Benzinga · Jul 15, 2026, 12:04 PM
Cardiff Oncology Announces $10M Registered Direct Offering Of 8,571,429 Shares An Accompanying Warrants At $1.05 Per Share And Accompanying WarrantBenzinga · Jul 15, 2026, 12:03 PM
Craig-Hallum Downgrades Cardiff Oncology to Hold, Lowers Price Target to $2Benzinga · Jun 3, 2026, 5:45 PM
Cardiff Oncology Announces Presentation Of Phase 2 Trial Data For RAS-Mutated mCRC Treatment Onvansertib At ASCO Annual Meeting On June 2Benzinga · Jun 2, 2026, 1:14 PM
Cardiff Oncology shares are trading lower after HC Wainwright & Co. downgraded the stock from Buy to Neutral. Also, TD Cowen downgraded its rating on the stock from Buy to Hold.Benzinga · Jun 1, 2026, 3:24 PM
TD Cowen Downgrades Cardiff Oncology to HoldBenzinga · Jun 1, 2026, 2:40 PM
This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For MondayBenzinga · Jun 1, 2026, 12:57 PM